Dr. Roger Engeli


Office phone
+41 (0)61 207 14 89
Office fax
+41 (0)61 207 15 15

Roger joined the Molecular and Systems Toxicology group at the University of Basel in September 2012. He studied  the impact of inflammatory states on promoter activation, relative gene expression and activity of 17β-HSD3 and AKR1C3 and graduated with a Master in Pharmaceutical Science in Spring 2013. He started his PhD within the same Molecular and Systems Toxicology  group at the University of Basel in July 2013




Latest Publications

Ben Rhouma, Bochra; Kallabi, Fakhri; Mahfoudh, Nadia; Ben Mahmoud, Afif; Engeli, Roger T.; Kamoun, Hassen; Keskes, Leila; Odermatt, Alex; Belguith, Neila: Novel cases of Tunisian patients with mutations in the gene encoding 17β-hydroxysteroid dehydrogenase type 3 and a founder effect, in: Journal of Steroid Biochemistry and Molecular Biology 165, 2017, H. Pt A, S. 86-94. edoc
Engeli, Roger T; Rhouma, Bochra Ben; Sager, Christoph P; Tsachaki, MariaBirk, Julia; Fakhfakh, Faiza; Keskes, Leila; Belguith, Neila; Odermatt, Alex: Biochemical analyses and molecular modeling explain the functional loss of 17β-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development, in: The Journal of steroid biochemistry and molecular biology 155, 2016, H. Pt A, S. 147-54. edoc
Odermatt, Alex; Strajhar, Petra; Engeli, Roger T: Disruption of steroidogenesis: Cell models for mechanistic investigations and as screening tools, in: The Journal of steroid biochemistry and molecular biology 158, 2016, S. 9-21. edoc

> All Publications